Testing the sense of smell to assess brain health in older adults
Official title: Digital Accessible Remote Olfactory Mediated Health Assessments for Preclinical AD
Run by Massachusetts General Hospital · NCT05881239 · Data updated 2026-11-12
This study is testing if a smell test can help identify brain health issues in older adults who have memory concerns or mild cognitive problems.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 250 (estimated) |
| Sponsor | Massachusetts General Hospital Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Status | Recruiting |
| Started | May 9, 2023 |
| Main results expected | December 30, 2026 |
| Study ends | December 31, 2027 |
| Registry record updated | March 6, 2026 |
| Trial ID | NCT05881239 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 to 100 with subjective cognitive concerns or mild cognitive impairment.
✕Probably not a fit
Patients with severe cognitive dysfunction or current respiratory issues may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate the sense of smell in participants with subjective cognitive concerns, mild cognitive impairment, and mild behavioral impairment, as well as age-matched controls. Participants will complete the AROMHA Brain Health Smell Test, which involves sniffing odor samples and answering related questions via a web-based app. The study seeks to determine if olfactory testing can serve as a predictive biomarker for neurodegenerative disorders, potentially leading to a noninvasive and cost-effective diagnostic tool. Results from the tests will not be disclosed to participants.
Why it matters
Potential benefit: If successful, this study could lead to a reliable method for early detection of neurodegenerative diseases.
How similar studies have gone: While olfactory testing has been explored in other contexts, this specific approach to assessing brain health is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * A clinical or research consensus diagnosis of the patient's condition or control status. * Individuals that are at least 18 years of age at the time of enrollment. * Individuals that are no older than 100 years of age at the time of enrollment. Exclusion Criteria: * Primary pulmonary disease such as severe emphysema or asthma not under good medical control. * Current sinusitis, common cold, upper respiratory infection, or nasal polyps. * Current or recent (past 6 months) alcohol or substance dependence. A prior history of alcohol or substance abuse will not be grounds for exclusion. * Pregnancy. * Severe cognitive dysfunction that would preclude completion of the olfactory testing. * An adverse reaction to fragrances (ie. they trigger a severe asthmatic attack or nausea).
Where it's running
-
Massachusetts General Hospital
Boston, Massachusetts, United States Recruiting
Study contacts
- Principal investigator: Mark W Albers, MD PhD — Massachusetts General Hospital
- Study coordinator: Mark W Albers, MD PhD
- Email: albers.mark@mgh.harvard.edu
- Phone: 617-724-7401
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using spatial navigation to detect early Alzheimer's disease.
This study is testing if using spatial navigation tasks can help spot early signs of Alzheimer's disease in people with mild cognitive impairment and mild dementia.
-
Effects of melatonin on brain health and cognition in older adults
This study is testing if taking 5mg of melatonin can improve brain health and thinking skills in older adults, especially those with mild cognitive impairment, over nine months.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Choose Myself (Before) Losing Myself
We’re testing an educational interactive booklet to help people with dementia or memory problems think about future medical decisions and start conversations with family or caregivers.
-
Gut and Oral Microbiome and Cognitive Health in Aging
This study tests whether differences in gut and mouth bacteria are linked to cognitive health in adults across ages and cognitive status.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.